SM-COLSARSPROT: Highly Immunogenic Supramutational Synthetic Peptides Covering the World’s Population

ABSTRACT: Fifty ~20–amino acid (aa)–long peptides were selected from functionally relevant SARSCoV-2 S, M, and E proteins for trial B-21 and another 53 common ones, plus some new ones derived from the virus’ main genetic variants for complementary trial C-21. Peptide selection was based on tremendou...

Full description

Autores:

Manuel A., Patarroyo
Patarroyo Murillo, Manuel Elkin
Pabón, Laura
Alba, Martha P
Bermúdez, Adriana
Rugeles López, María Teresa
Díaz Arevalo, Diana
Zapata Builes, Wildeman
Zapata Cardona, María Isabel
Flórez Álvarez, Lizdany
Aguilar Jimenez, Wbeimar
Reyes, César
Suarez, Carlos F
Agudelo, William
López, Carolina
Aza Conde, Jorge
Melo, Miguel
Escamilla, Luis
Oviedo, Jairo
Guzmán, Fanny
Silva, Yolanda
Forero, Martha
Moreno Vranich, Armando
Garry, Jason
Avendaño, Catalina

Tipo de recurso:

Article of investigation

Fecha de publicación:

2022

Institución:

Universidad de Antioquia

Repositorio:

Repositorio UdeA

Idioma:

eng

OAI Identifier:

oai:bibliotecadigital.udea.edu.co:10495/35481

Acceso en línea:

https://hdl.handle.net/10495/35481

Palabra clave:

SARS-CoV-2
Péptidos
Peptides
Secuencia de Aminoácidos
Amino Acid Sequence
Vacunas contra la COVID-19
COVID-19 Vaccines
Antígenos de Histocompatibilidad Clase II
Histocompatibility Antigens Class II
Antígenos
Antigens
Enfermedades Transmisibles
Communicable Diseases

Rights

openAccess

License

https://creativecommons.org/licenses/by/4.0/